Having received floods of questions from victims who suffered from the recently disclosed Samsung BioLogics’ accounting fraud scandal, Hannuri Law has been reviewing and working on evaluation of the case, and established a plan to file a securities-related class action as soon as possible. However, we recently changed our plan and decided to postpone filing the suit until FSC rules on the accounting fraud issue in order to have a more informed decision.
If you have already sent power of attorney
documents or indicated intention of litigation, please be patient until we
contact you individually after the FSC’s ruling.